Chemotherapy

The FDA approved Vyloy with chemotherapy to treat locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma in adults, according to a press release.

Concurrent administration of chemoradiation and immunotherapy did not improve survival for patients with limited-stage small cell lung cancer, according to a study presented at American Society for Radiation Oncology Annual Meeting.

Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.

A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.

Self-identifying transgender individuals assigned female at birth face three key barriers when seeking care for breast or gynecologic cancers, according to results of a qualitative study published in JAMA Network Open.

A blood test for men at the time of a metastatic prostate cancer diagnosis may predict treatment response and survival, according to study results.

Breast Cancer Awareness Month is observed every October.

Inpatient management of people with cancer varied considerably based on their housing status, according to results of a cross-sectional study.

The FDA expanded the approval of nivolumab for treatment of non-small cell lung cancer.

Extended lymphadenectomy offered no survival benefit for patients with localized muscle-invasive bladder cancer compared with bilateral standard lymphadenectomy for patients undergoing radical cystectomy, according to study findings.